Major Pharma News Highlights, October to December 2017

FavoriteLoadingAdd to favorites

Torrent Pharma to buy Unichem’s India business:

Torrent Pharmaceuticals  has entered into a agreement with Unichem to buy its business in India, Nepal for Rs3,600 crore.

Ajanta Pharma retains the tag of fastest wealth creator for the third time in a row:

TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastestweath creator in 2017. Asian Paints is the most consistent wealth creator, said the wealth creation study.

The Hyderabad Pharma City:

The Hyderabad Pharma City project in its entirety will be spread over 19,333 acres, attract an investment of about ₹ 64,000 crore and provide direct employment to 1.7 lakh people, Industries Minister K.T. Rama Rao said here on Tuesday.

69th Indian Pharmaceutical Congress (IPC):

69th Indian Pharmaceutical Congress (IPC), a three day international Conference between December 22-24, 2017, held at Chitkara University, Punjab campus.

Mankind Pharma has appointed superstar Amitabh Bachchan as brand ambassador:

And through this partnership it will emphasise the importance of good health and affordable treatment for all.

Fish continues to be victim of pharma growth:

Nearly 23 lakh fish have died in Telangana’s Gandigudem Lake due to the pollutants present in the water body.
The police have registered a case against five pharma companies found guilty of causing pollution under section 277 (fouling water of public spring or reservoir) and 278 (making the atmosphere noxious to health) of IPC.

Earlier this year, 30,000 fish were found dead in Rampally Lake, located 30 kilometres from Hyderabad; 40,000 fish were found floating in Shamirpet Lake and over 20,000 fish died in Medchal.

Dept of Pharma sets up committee to assist on pricing, new drug launches:

The committee will look at the claims made by the respective companies on any additional therapeutic claims made by companies on new drugs, and provide a recommend separate ceiling price of the scheduled formulation or retail price of a new drug.

CPhI Global Pharma Index:

As the CPhI Global Pharma Index shows that the India’s efforts to improve its reputation are paying dividends. India emerged successful in a number of key areas and was ranked by international pharma companies as the third most competitive nation globally.

Sun Pharma climbs 3% after USFDA accepts new drug application:

USFDA accepts new drug application for  a ophthalmic drug  OTX-101 (cyclosporine A, ophthalmic solution) from wholly owned sun Pharma subsidiary.

Indian drug companies face probe in USA:

Major Indian drug companies such as Dr Reddy’s Laboratories (DRL), Sun Pharmaceutical Industries and Glenmark Pharmaceuticals are likely to face probe in the US following complaints of artificially inflating prices of generic drugs.

Karnataka is planning to establish ‘Pharma Park’ soon:

Karnataka is planning to establish a ‘Pharma Park’ . The state government has identified a few locations and is expected to finalise the same at the earliest. Under evaluation locations  include Nanjangud in Mysuru, Chamrajanagar off Mysuru, Kanakapura in the outskirts of Bengaluru and Hubballi-Dharwad in north Karnataka.

Pharma Gets Boost as China Speeds Up New Drug Approvals:

Overseas clinical trials will be accepted, Xinhua reports. Changes will likely shorten delays in access to new treatments.That removes the need for manufacturers to conduct added tests in China after receiving overseas approvals.


Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar